Last update 21 Nov 2024

Autologous BCMA CAR-T(The First Affiliated Hospital of Xiamen University)

Overview

Basic Info

Drug Type
Autologous CAR-T
Synonyms
Chimeric Antigen Receptor Modified T Cells Targeting BCMA(The First Affiliated Hospital of Xiamen University)
Target
BCMA
Mechanism
BCMA modulators(B-cell maturation protein modulators)
Therapeutic Areas
NeoplasmsImmune System DiseasesCardiovascular Diseases+ [1]
Active Indication
Multiple Myeloma
Inactive Indication-
Originator Organization
The First Affiliated Hospital of Xiamen University
Active Organization
The First Affiliated Hospital of Xiamen University
Inactive Organization-
Drug Highest PhasePhase 2
First Approval Date-
Regulation-
Login to view timeline

Related

2
Clinical Trials associated with Autologous BCMA CAR-T(The First Affiliated Hospital of Xiamen University)
ChiCTR2400091449 / SuspendedNot ApplicableIIT
Exploratory clinical study on the safety, tolerability, and efficacy of Chimeric Antigen Receptor T Cells Targeting BCMA Injection in the treatment of refractory or recurrent multiple myeloma
NCT06581640 / RecruitingPhase 2IIT
A Clinical Study of the Safety and Efficacy of Chimeric Antigen Receptor-modified T Cells Targeting BCMA for the Treatment of Relapsed/Refractory Multiple Myeloma
100 Clinical Results associated with Autologous BCMA CAR-T(The First Affiliated Hospital of Xiamen University)
Login to view more data
100 Translational Medicine associated with Autologous BCMA CAR-T(The First Affiliated Hospital of Xiamen University)
Login to view more data
100 Patents (Medical) associated with Autologous BCMA CAR-T(The First Affiliated Hospital of Xiamen University)
Login to view more data
100 Deals associated with Autologous BCMA CAR-T(The First Affiliated Hospital of Xiamen University)
Login to view more data

R&D Status

10 top R&D records.
Login
to view more data
IndicationHighest PhaseCountry/LocationOrganizationDate
Multiple MyelomaPhase 2
CN
The First Affiliated Hospital of Xiamen University
24 Sep 2024
Login to view more data

Clinical Result

Indication
Phase
Evaluation
View All Results
Study
Phase
PopulationAnalyzed EnrollmentGroupResultsEvaluationPublication Date

No Data

Login to view more data

Translational Medicine

Boost your research with our translational medicine data.
login
or
view full example data
Boost your research with our translational medicine data.

Deal

Boost your decision using our deal data.
login
or
view full example data
Boost your decision using our deal data.

Core Patent

Boost your research with our Core Patent data.
login
or
view full example data
Boost your research with our Core Patent data.

Clinical Trial

Identify the latest clinical trials across global registries.
login
or
view full example data
Identify the latest clinical trials across global registries.

Approval

Accelerate your research with the latest regulatory approval information.
login
or
view full example data
Accelerate your research with the latest regulatory approval information.

Regulation

Understand key drug designations in just a few clicks with Synapse.
login
or
view full example data
Understand key drug designations in just a few clicks with Synapse.
Chat with Hiro
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free